Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1988-12-8
|
pubmed:abstractText |
The duration of respiratory depression induced by morphine 10 mg/70 kg was studied following the administration of one of two opioid antagonists. Respiratory measurements included: (i) the ventilatory response to carbon dioxide, described in two ways--the minute ventilation at an end-tidal carbon dioxide partial pressure of 8 kPa (VE8) and the log slope of the ventilatory response to carbon dioxide; (ii) resting end-tidal carbon dioxide partial pressure; (iii) rate of ventilation. One hour after administration of morphine, one of the following was given i.v.: nalmefene 0.4 mg/70 kg; naloxone 0.4 mg/70 kg (low dose); naloxone 1.6 mg/70 kg (high dose); or saline placebo. The depression of VE8 by morphine was antagonized by all three treatments for the 1.5 h after the injection. However, for the 1.5-6 h after antagonist, VE8 following naloxone became depressed, whereas VE8 after nalmefene remained significantly increased compared with other treatments. Nalmefene restored the slope of the ventilatory response to baseline for 6 h and differed significantly from low but not high dose naloxone. Resting end-tidal carbon dioxide measurements demonstrated that nalmefene activity exceeded that of low but not high dose naloxone over the 1.5-4.5 h period. Rate of ventilation was not different between treatments.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Dioxide,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone,
http://linkedlifedata.com/resource/pubmed/chemical/Naltrexone,
http://linkedlifedata.com/resource/pubmed/chemical/Narcotic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/nalmefene
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0007-0912
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
318-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3140862-Adult,
pubmed-meshheading:3140862-Carbon Dioxide,
pubmed-meshheading:3140862-Depression, Chemical,
pubmed-meshheading:3140862-Humans,
pubmed-meshheading:3140862-Male,
pubmed-meshheading:3140862-Middle Aged,
pubmed-meshheading:3140862-Morphine,
pubmed-meshheading:3140862-Naloxone,
pubmed-meshheading:3140862-Naltrexone,
pubmed-meshheading:3140862-Narcotic Antagonists,
pubmed-meshheading:3140862-Partial Pressure,
pubmed-meshheading:3140862-Respiration,
pubmed-meshheading:3140862-Time Factors
|
pubmed:year |
1988
|
pubmed:articleTitle |
Antagonism of morphine-induced respiratory depression with nalmefene.
|
pubmed:affiliation |
Division of Anaesthesia, Northwick Park Hospital, Harrow, Middx.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|